CTRI/2023/06/053727已完成Unknown
An open label, prospective, non-comparative, multicenter study to evaluate asthma control and device usability of Budesonide-Formoterol delivered through CiphalerTM in subjects with Asthma.
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- Cipla Ltd
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. A voluntarily given written, signed dated informed consent from subjects and/or legally acceptable representative. 2. Subjects of either gender of age 18 years or above with documented diagnosis of Asthma. 3. Subjects receiving Budesonide-Formoterol through the Rotahaler, who have uncontrolled asthma. and in the Investigator’s opinion can be switched to treatment with Budesonide-Formoterol Ciphaler. 4. Subjects able to use Ciphaler correctly during course of the study and able to comply with the study protocol.
排除标准
- •1. Hypersensitivity to study drug or any of its components. 2. Subjects using devices other than Rotahaler. 3. Previous experience with the use of Ciphaler.
研究者
相似试验
招募中
4 期
A clinical study to understand the effect of Remdesivir intravenous injection in hospitalized moderate to severe Covid-19 patients.CTRI/2022/03/041252CiplaLtd
已完成
3 期
To determine the safety and efficacy of Etanercept for injection 25 mg in patients with moderate to severe active rheumatoid arthritis.CTRI/2009/091/000399Cipla Ltd R and D Centre LBS Marg Vikhroli W Mumbai100
进行中（未招募）
4 期
An open label, phase IV trial of Glycopyrronium/Formoterol/Budesonide (25mcg/12mcg/400mcg) fixed dose triple combination (FDC) in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).CTRI/2021/08/035992Cipla Ltd
尚未招募
4 期
Open label, prospective, non-comparative, multicentric, phase IV clinical study of Iguratimod tablets 25 mgCTRI/2022/03/041073Ajanta Pharma Limited
尚未招募
4 期
A clinical study to evaluate the safety and efficacy of Tropicamide, Phenylephrine and Lidocaine injection in patients undergoing lens replacement surgery.CTRI/2024/01/062038Appasamy Ocular Devices (P) Ltd.